Results 1 to 10 of about 125,774 (261)

Intravenous calcium therapy in calcium channel blocker poisoning - A double-edged sword. [PDF]

J Anaesthesiol Clin Pharmacol
Rajaram B, Ravikumar RH, Sharma S, Khanna P.   +3 more
europepmc   +1 more source

Calcium Channel Blocker Versus Renin-Angiotensin System Inhibitor in Risk of Kidney Cancer Among Patients With Hypertension: A Propensity Score-Matched Cohort Study. [PDF]

Cancer Med
Jung M, Li S, Deng Z, Li J, Li M, Basran S, Langston ME, Chung BI.   +7 more
europepmc   +1 more source

Improvement in oxygenation with a calcium channel blocker in a patient with hepatopulmonary syndrome during tacrolimus therapy following living donor liver transplantation - A case report. [PDF]

Indian J Anaesth
Yakushiji T, Honda J, Hosono A, Inoue S.
europepmc   +1 more source

CaBind_MCNN: Identifying Potential Calcium Channel Blocker Targets by Predicting Calcium-Binding Sites in Ion Channels and Ion Transporters Using Protein Language Models and Multiscale Feature Extraction. [PDF]

J Chem Inf Model
Chang YY, Liu YC, Jhang WE, Wei SS, Ou YY.   +4 more
europepmc   +1 more source

Antiproliferative effect of low-level laser/ photobiomodulation on gingival fibroblasts derived from calcium channel blocker-induced gingival overgrowth. [PDF]

Lasers Med Sci
Slezovic MÖ, Saygun I, Bengi VU, Serdar M, Kantarci A.   +4 more
europepmc   +1 more source

Predictors of Mortality in Adults With Calcium Channel Blocker Toxicity Receiving Extracorporeal Membrane Oxygenation Support: An Extracorporeal Life Support Organization Registry Analysis. [PDF]

ASAIO J
Subramanian R, Roebuck A, Joshi H, Drouin M.   +3 more
europepmc   +1 more source

Rationale and Design of a Randomized, Open-Label, Parallel-Group Study of Esaxerenone Versus Angiotensin Receptor Blockers in Older Patients With Uncontrolled Hypertension on Calcium Channel Blocker Monotherapy (ESCORT-HT). [PDF]

J Clin Hypertens (Greenwich)
Kario K, Katsuya T, Shimosawa T, Taguchi T, Tanabe A, Ohishi M, ESCORT‐HT investigators.   +6 more
europepmc   +1 more source

Validation of L-type calcium channel blocker amlodipine as a novel ADHD treatment through cross-species analysis, drug-target Mendelian randomization, and clinical evidence from medical records. [PDF]

Neuropsychopharmacology
Þorsteinsson H, Baukmann HA, Sveinsdóttir HS, Halldórsdóttir DÞ, Grzymala B, Hillman C, Rolfe-Tarrant J, Parker MO, Cope JL, Ravarani CNJ, Schmidt MF, Karlsson KÆ.   +11 more
europepmc   +1 more source

Home blood pressure-lowering effect of esaxerenone versus trichlormethiazide for uncontrolled hypertension: a predefined subanalysis of the EXCITE-HT randomized controlled trial by basal calcium channel blocker versus angiotensin receptor blocker. [PDF]

Hypertens Res
Kario K, Ohbayashi H, Hashimoto M, Itabashi N, Kato M, Uchiyama K, Hirano K, Nakamura N, Miyamoto T, Nagashima H, Ishida H, Ebe Y, Hatta T, Fukui T, Shimosawa T, Katsuya T, Taguchi T, Tanabe A, Ohishi M, EXCITE-HT investigators.   +19 more
europepmc   +1 more source